CELLECTIS
DEAD

Serial Number

76210656

Owner

Cellectis S.A.

Attorney

Mary Margaret L. O'Donnell

Filing Date

Feb 13, 2001

Add to watchlist:

No watchlists yet
View on USPTO

CELLECTIS Trademark

Serial Number: 76210656 • Registration: 2875210

CELLECTIS is a trademark filed by Cellectis S.A. on February 13, 2001. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Cellectis S.A. (9 trademarks)

8 rue de la Croix
Paris 75013 , FR

Entity Type: 16

Trademark Details

Filing Date

February 13, 2001

Registration Date

August 17, 2004

Published for Opposition

February 18, 2003

Cancellation Date

February 28, 2025

Goods & Services

Scientific devices and instruments enabling implementation of biochemical analysis techniques and molecular biology techniques, namely, automated biochemical analyser, automated protein production and protein purification devices, biochemical, biological automated assay devices, nucleic acid break analyser, analyzer for automatically measuring and researching interactions of biomolecule, devices for protein-nucleic acid interaction analysis; apparatus for use in analysis and array-tests, qualitative and quantitative detection of analytes in samples, namely, DNA sequencing, receptor-ligand interaction, protein analysis, mass-spectrometry, nucleic acid hybridization and detection, thermo-cycler systems, microarray-printer, microarray-reader; scientific devices and instruments enabling the mapping of the biological activities of all molecules; information processing equipment, namely, computer software for molecular design, sequence analysis, sequence generation, design and analysis of molecules, namely, polypeptides or polynucleotides used in genetic engineering, design and analysis of genetic recombination systems, hardware and component parts, namely, processors, memory banks, peripheral controllers; multimedia products, namely, prerecorded magnetic tapes, CD-ROMS, containing image and sound recordings in the fields of chemistry, biology, biochemistry, molecular biology, bacteriology; software programs namely, software for providing an on-line computer database in the field of pharmaceuticals and biotechnology; software for searching, retrieving, storing, maintaining and managing data in the field of pharmaceuticals and biotechnology; software for use in the field of scientific information management; software for use in drug discovery; software for biomolecules analysis, nucleic acids and proteins sequences evaluation, chemical, medical and biological data bank searches and analysis, physiological data analysis, genetic data analysis, chemical formulae analysis, structural predication for biological and chemical molecules; software for writing biological molecule sequence; molecular design software for analysis, simulation and design of biological, chemical, and material systems; software for molecular design in the biotechnology and pharmaceutical field; software for use in biological and chemical modeling, analysis and information management; software for integrated global management

Pharmaceutical, veterinary and health-care products, namely polypedtides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors, ready to use genomic recombination system, cells engineered by meganuclease recombination system for use in genetic or viral diseases; microorganism cultures and preparation for medical, pharmaceutical and veterinary use, namely microorganisms engineered by meganuclease recombination system for use in genetic or viral diseases, cancers and vaccines; microorganisms producing polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors, ready to use genomic recombination system for use in genetic or viral diseases; bacteriological preparations for medical, pharmaceutical and veterinary use namely bacteriological preparations engineered by meganuclease recombination system; bacteriological preparations producing polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors, ready to use genomic recombination system; drugs for veterinary use, namely polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors for use in genetic or viral diseases; biological preparation for medical, pharmaceutical and veterinary use namely polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, moelcular scissors, ready to use genomic recombination system, cells engineered by meganuclease recombination system for use in genetic or viral diseases; chemopharmaceutical preparations; diagnostic preparations for clinical or medical laboratory use

Chemical, biochemical, biotechnological products intended for industry, agriculture,horticulture, namely, polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors; ready to use genomic recombination system, namely, meganuclease recombination agents for use in genetic engineering of cells and animals, namely, rodents and fish, for scientific, laboratory or medical research; chemical, biochemical, biotechnological and bacteriological products intended for research laboratories and control laboratories, namely, polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors; ready to use genomic recombination agents for use in connection with cells and animals for scientific, laboratory or medical research; chemical, biochemical, biotechnological products and bacteriological preparations for sciences, namely polypeptides for in vivo and in vitro genetic engineering; natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors; ready to use genomic recombination agents for use in connection with cells and animals for scientific, laboratory or medical research; diagnostic preparation, namely natural and engineered meganucleases and endocnucleases, molecular scissors for scientific or research use; proteins as raw materials; microorganisms used for producing therapeutical compounds or vaccines; chemical and biochemical preparations for medical, pharmaceutical and veterinary use, namely polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors; ready to use genomic recombination agents for scientific or research use

Scientific and industrial research; research in genetic, medical, pharmaceutical and veterinary fields; research in chemistry, biology, biochemistry, molecular biology, bacteriology; scientific analysis; research and development for others of techniques of biochemical analysis, biological analysis, molecular biology techniques; research and development for others of new molecules intended for industry; laboratory research in the fields of biotechnology, human and veterinary medicine, genetic engineering, protein design, drug design, genetic therapy, molecular biology, agriculture; medical services; studies of technical projects in the field of biotechnology, human and veterinary medicine, genetic engineering, protein design, drug design, genetic therapy, molecular biology, agriculture; testing, analysis and evaluation of engineering works for others; licensing of patents and intellectual property; computer programming for others; development for others of software programs

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Feb 28, 2025 CAEX
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 18, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Oct 18, 2023 ECDR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Oct 18, 2023 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 18, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 18, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 18, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 18, 2023 COAR
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Aug 17, 2023 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Feb 18, 2015 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Feb 18, 2015 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Feb 18, 2015 89AG
TEAS SECTION 8 & 9 RECEIVED
Feb 17, 2015 E89R
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 10, 2015 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 10, 2015 COAR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sep 1, 2010 C15P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 27, 2010 APRE
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Aug 6, 2010 815F
TEAS SECTION 8 & 15 RECEIVED
Aug 6, 2010 E815
REGISTERED-PRINCIPAL REGISTER
Aug 17, 2004 R.PR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 1, 2004 CNPR
ASSIGNED TO EXAMINER
May 26, 2004 DOCK
STATEMENT OF USE PROCESSING COMPLETE
May 26, 2004 SUPC
CASE FILE IN TICRS
May 21, 2004 CFIT
PAPER RECEIVED
May 11, 2004 MAIL
USE AMENDMENT FILED
May 11, 2004 IUAF
PAPER RECEIVED
May 11, 2004 MAIL
SOU EXTENSION 1 GRANTED
Dec 9, 2003 EX1G
SOU EXTENSION 1 FILED
Nov 13, 2003 EXT1
PAPER RECEIVED
Nov 13, 2003 MAIL
NOA MAILED - SOU REQUIRED FROM APPLICANT
May 13, 2003 NOAM
PUBLISHED FOR OPPOSITION
Feb 18, 2003 PUBO
NOTICE OF PUBLICATION
Jan 29, 2003 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 16, 2002 CNSA
EXAMINERS AMENDMENT MAILED
Nov 22, 2002 CNEA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 30, 2002 CRFA
PAPER RECEIVED
Sep 30, 2002 MAIL
FINAL REFUSAL MAILED
May 20, 2002 CNFR
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 21, 2001 CRFA
NON-FINAL ACTION MAILED
Jun 15, 2001 CNRT
ASSIGNED TO EXAMINER
Jun 12, 2001 DOCK